Further evidence for a male-selective genetic association of synapse-associated protein 97 (SAP97) gene with schizophrenia

Behavioral and Brain Functions

Volumn 8, Issue , 2012, Pages

  Uezato, Akihito ^a,b   Kimura Sato, Junko ^a   Yamamoto, Naoki ^a   Iijima, Yoshimi ^c   Kunugi, Hiroshi ^c   Nishikawa, Toru ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

Gender selective; Genetic association; Glutamate; SAP97; Scaffolding protein; Schizophrenia; Single nucleotide polymorphisms; Synapse associated protein

Indexed keywords

MEMBRANE PROTEIN; SYNAPSE ASSOCIATED PROTEIN 97; UNCLASSIFIED DRUG; DLG1 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS (TOPIC); PRIORITY JOURNAL; RISK ASSESSMENT; SCHIZOPHRENIA; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; ASIAN; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; JAPAN; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; RECESSIVE GENE; SEXUAL DEVELOPMENT;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENES, RECESSIVE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; JAPAN; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; SEX CHARACTERISTICS;

EID: 84855455351     PISSN: None     EISSN: 17449081     Source Type: Journal    
DOI: 10.1186/1744-9081-8-2     Document Type: Article

References (33)

1. McGuffin P, Owen M, Farmer A. Genetic basis of schizophrenia. Lancet 1995, 346:678-682. 10.1016/S0140-6736(95)92285-7, 7658823.
2. Allen N, Bagade S, McQueen M, Ioannidis J, Kavvoura F, Khoury M, Tanzi R, Bertram L. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet 2008, 40:827-834. 10.1038/ng.171, 18583979.
3. Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 1991, 148:1301-1308.
4. Nishikawa T, Hashimoto A, Tanii Y, Umino A, Kashiwa A, Oka T, Nishijima K, Takahashi K. Excitatory amino acidergic dysfunction and schizophrenia. Journal of Neurochemistry 1992, 59:S2-S2.
5. Reich D, Silvay G. Ketamine: an update on the first twenty-five years of clinical experience. Can J Anaesth 1989, 36:186-197. 10.1007/BF03011442, 2650898.
6. White P, Way W, Trevor A. Ketamine--its pharmacology and therapeutic uses. Anesthesiology 1982, 56:119-136. 10.1097/00000542-198202000-00007, 6892475.
7. Schwartz R, Einhorn A. PCP intoxication in seven young children. Pediatr Emerg Care 1986, 2:238-241. 10.1097/00006565-198612000-00008, 3797269.
8. Welch M, Correa G. PCP intoxication in young children and infants. Clin Pediatr (Phila) 1980, 19:510-514.
9. Buchanan R, Carpenter W. Concept of Schizophrenia. Kaplan & Sadock's Comprehensive Textbook of Psychiatry 2005, 1329-1345. New York: Lippincott Williams & Wilkins (LWW), Sadock B, Sadock V, 8.
10. Takebayashi H, Yamamoto N, Umino A, Nishikawa T. Developmentally regulated and thalamus-selective induction of leiomodin2 gene by a schizophrenomimetic, phencyclidine, in the rat. Int J Neuropsychopharmacol 2009, 1-16.
11. Sato D, Umino A, Kaneda K, Takigawa M, Nishikawa T. Developmental changes in distribution patterns of phencyclidine-induced c-Fos in rat forebrain. Neurosci Lett 1997, 239:21-24. 10.1016/S0304-3940(97)00879-3, 9547162.
12. Scalzo F, Burge L. The role of NMDA and sigma systems in the behavioral effects of phencyclidine in preweanling rats. Neurotoxicology 1994, 15:191-200.
13. Howard M, Elias G, Elias L, Swat W, Nicoll R. The role of SAP97 in synaptic glutamate receptor dynamics. Proc Natl Acad Sci USA 2010, 107:3805-3810. 10.1073/pnas.0914422107, 2840522, 20133708.
14. Hiraoka S, Kajii Y, Kuroda Y, Umino A, Nishikawa T. The development- and phencyclidine-regulated induction of synapse-associated protein-97 gene in the rat neocortex. Eur Neuropsychopharmacol 2010, 20:176-186. 10.1016/j.euroneuro.2009.08.007, 19836928.
15. Sato J, Shimazu D, Yamamoto N, Nishikawa T. An association analysis of synapse-associated protein 97 (SAP97) gene in schizophrenia. J Neural Transm 2008, 115:1355-1365. 10.1007/s00702-008-0085-9, 18665322.
16. Otsubo T, Miyaoka H, Kamijima K. M.I.N.I. Mini international neuropsychiatric interview. 2005, Tokyo: Seiwa Shoten Publishers.
17. Sheehan D, Lecrubier Y, Sheehan K, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar G. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998, 59(Suppl 20):22-33. quiz 34-57.
18. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007, 81:559-575. 10.1086/519795, 1950838, 17701901.
19. Ioannidis J, Ntzani E, Trikalinos T, Contopoulos-Ioannidis D. Replication validity of genetic association studies. Nat Genet 2001, 29:306-309. 10.1038/ng749, 11600885.
20. Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, Pe'er I, Dudbridge F, Holmans PA, Whittemore AS, Mowry BJ, et al. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 2009, 460:753-757. 2775422, 19571809.
21. Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D, Werge T, Pietiläinen OP, Mors O, Mortensen PB, et al. Common variants conferring risk of schizophrenia. Nature 2009, 460:744-747. 3077530, 19571808.
22. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, Sklar P, Consortium IS. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460:748-752.
23. Mulle JG, Dodd AF, McGrath JA, Wolyniec PS, Mitchell AA, Shetty AC, Sobreira NL, Valle D, Rudd MK, Satten G, et al. Microdeletions of 3q29 confer high risk for schizophrenia. Am J Hum Genet 2010, 87:229-236. 10.1016/j.ajhg.2010.07.013, 2917706, 20691406.
24. Kimchi-Sarfaty C, Oh J, Kim I, Sauna Z, Calcagno A, Ambudkar S, Gottesman M. A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science 2007, 315:525-528. 10.1126/science.1135308, 17185560.
25. Hammond J, McCullumsmith R, Funk A, Haroutunian V, Meador-Woodruff J. Evidence for abnormal forward trafficking of AMPA receptors in frontal cortex of elderly patients with schizophrenia. Neuropsychopharmacology 2010, 35:2110-2119. 10.1038/npp.2010.87, 2922423,2922423, 20571483.
26. Toyooka K, Iritani S, Makifuchi T, Shirakawa O, Kitamura N, Maeda K, Nakamura R, Niizato K, Watanabe M, Kakita A, et al. Selective reduction of a PDZ protein, SAP-97, in the prefrontal cortex of patients with chronic schizophrenia. J Neurochem 2002, 83:797-806. 10.1046/j.1471-4159.2002.01181.x, 12421351.
27. Dracheva S, McGurk S, Haroutunian V. mRNA expression of AMPA receptors and AMPA receptor binding proteins in the cerebral cortex of elderly schizophrenics. J Neurosci Res 2005, 79:868-878. 10.1002/jnr.20423, 15696539.
28. Nakagawa T, Futai K, Lashuel H, Lo I, Okamoto K, Walz T, Hayashi Y, Sheng M. Quaternary structure, protein dynamics, and synaptic function of SAP97 controlled by L27 domain interactions. Neuron 2004, 44:453-467. 10.1016/j.neuron.2004.10.012, 15504326.
29. Yuen EY, Yan Z. Cellular mechanisms for dopamine D4 receptor-induced homeostatic regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors. J Biol Chem 2011, 286:24957-24965. 10.1074/jbc.M111.221416, 21622557.
30. Hennah W, Varilo T, Kestilä M, Paunio T, Arajärvi R, Haukka J, Parker A, Martin R, Levitzky S, Partonen T, et al. Haplotype transmission analysis provides evidence of association for DISC1 to schizophrenia and suggests sex-dependent effects. Hum Mol Genet 2003, 12:3151-3159. 10.1093/hmg/ddg341, 14532331.
31. Shifman S, Johannesson M, Bronstein M, Chen S, Collier D, Craddock N, Kendler K, Li T, O'Donovan M, O'Neill F, et al. Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women. PLoS Genet 2008, 4:e28. 10.1371/journal.pgen.0040028, 2242812, 18282107.
32. Kim B, Kim H, Joo Y, Lim J, Kim C, Song K. Sex-different association of DAO with schizophrenia in Koreans. Psychiatry Res 2010, 179:121-125. 10.1016/j.psychres.2008.08.009, 20483168.
33. Leung A, Chue P. Sex differences in schizophrenia, a review of the literature. Acta Psychiatrica Scandinavica 2000, 101:3-38.